During his career, Riker has been recognized several times for his scientific achievements and his contributions to cancer care. Most recently, he was awarded the Pfizer Award for Scientific Achievement in Breast Cancer. The Pfizer Award is made annually to an academic scientist whose innovative research has made a significant impact on patients with breast cancer. The award was given for his annual efforts in traveling to several major cancer centers in China in an attempt to train breast surgeons in performing breast conserving surgery (lumpectomy) in addition to leading-edge surgical techniques, such as sentinel node mapping procedures.
Riker received his medical degree from the University of South Florida College of Medicine. He completed his internship and residency training in general surgery at Loyola University Medical Center in Chicago. Additionally, he has completed a three-year surgical oncology fellowship at the National Institutes of Health (NIH), National Cancer Institute, Surgery Branch.
Currently, Riker has several research projects funded through the NIH, the American Cancer Society and the H. Lee Moffitt Cancer Center and Research Institute. His primary research interests are focused on the development of novel vaccination strategies for patients with advanced cancer. He is also interested in the biobanking of cancer tissues for future immunologic, genetic and molecular analysis.
Riker is a Fellow of the American College of Surgeons and a founding member of the Society for Melanoma Research. He is an active member of numerous medical and surgical societies and is a peer reviewer for several medical journals. In 2004, Riker was named one of America’s Top Surgeons in Surgical Oncology.
Riker will join USA’s team of cancer specialists in July 2006. |